A St. Louis resident experienced partial respiratory paralysis after receiving an overdose of Botox at the St. Louis University Hospital recently. He was being treated for muscle spasticity, and Botox was being used for one of its off-label purposes in this particular case.
The patient Richard Hart suffers from a medical condition that affects his neck, and reportedly received 300 units of Botox on August 20, 2007, 200 units on September 20, 2007 and 400 units on October 5, 2007. By the middle of October that same year, Hart reported breathing problems and difficulty swallowing. The effects continued, and resulted in blurred vision, muscle weakness and the partial paralysis of his respiratory muscles.
The lawsuit alleges that the doctor who administered the drug was negligent and did not accurately monitor Hart’s Botox doses. If the doctor had maintained the recommended dosage schedule, Richard Hart may not have experienced any of the side effects or had to deal with the eventual partial failure of his respiratory system.
Mr. Hart’s case is being represented by the Lowe Law Firm based in St. Louis, a firm that handles a variety of personal injury, medical malpractice, product liability and commercial cases throughout the United States. According to Jeff Lowe, one of the attorneys representing Dr. Hart, “Botulism is one of the most toxic substances known to man. My client suffers from botulism poisoning, a painful and terminal illness.”
The U.S. Food and Drug Administration has already taken a stand on the potential risks and dangers of Botox, requiring that a warning is added to the packaging of all botulinum toxin products. The FDA requires that the Botox warning label explains that toxins can spread from the injection site to other areas of the body, and that they may also be the cause of many symptoms associated with botulism.